+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Smoking Cessation & Nicotine De-Addiction Product Market by Product, Distribution - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968933
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Smoking Cessation & Nicotine De-Addiction Product Market grew from USD 28.25 billion in 2023 to USD 30.89 billion in 2024. It is expected to continue growing at a CAGR of 9.65%, reaching USD 53.87 billion by 2030.

The smoking cessation and nicotine de-addiction product market encompasses a range of products such as nicotine replacement therapies (NRTs), prescription medications, and behavioral therapies designed to aid individuals in quitting smoking and overcoming nicotine addiction. The necessity for these products arises from the growing awareness of the health risks associated with smoking, increasing government initiatives to reduce smoking rates, and the societal shift towards healthier lifestyles. The application of these products spans across healthcare settings, corporate wellness programs, and individual consumers seeking to quit smoking. The end-use scope varies, targeting a broad demographic including young adults, middle-aged users, and even older adults who wish to quit long-standing habits.

Key factors influencing market growth include an increase in tobacco-related health disorders, rising consumer awareness, and technological advancements in product offerings, such as smartphone apps for behavioral therapy. Additionally, e-cigarettes and vaping alternatives, while sometimes part of cessation programs, have created a blurred line in the market dynamics. A significant potential opportunity lies in the integration of digital health technologies to personalize quitting journeys, creating a seamless support system for users. Companies are recommended to invest in research avenues that explore the combined effects of pharmacological and behavioral therapies. However, challenges persist, including stringent regulatory requirements, social stigmas, and the addictive nature of nicotine that makes user retention a challenge.

Innovation could focus on improving the efficiency of NRTs and expanding behavioral therapy through artificial intelligence and machine learning to provide customizable solutions for users. The market remains highly competitive and is subject to regulatory scrutiny, making adaptive compliance and strategic partnerships vital for growth. By focusing on these areas, businesses can enhance their product mixes, increase their market share, and propel market progress while overcoming the inherent limitations of consumer adherence to cessation protocols.

Understanding Market Dynamics in the Smoking Cessation & Nicotine De-Addiction Product Market

The Smoking Cessation & Nicotine De-Addiction Product Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing Prevalence of Numerous Diseases due to Smoking Such as Respiratory Disorders and Lung Cancer
    • Expanding Market Penetration of De-Addiction Products Globally
    • Favorable Government Initiatives to Promote Anti-Smoking Policy and Raising Awareness of the Health Impact due to Smoking
  • Market Restraints
    • Product Recalls by the Manufacturer and Companies owing to increasing Technical Faults and Stringent Approval Process
  • Market Opportunities
    • Increasing Approvals and Development of New Nicotine Replacement Products
    • Significant Online Market Presence Coupled with Social and Communal Support for Smoking Cessation Products
  • Market Challenges
    • Side Effects Associated with the Continued Usage of De-Addiction Products Coupled with Rising of Alternatives to Tobacco

Exploring Porter’s Five Forces for the Smoking Cessation & Nicotine De-Addiction Product Market

Porter’s Five Forces framework further strengthens the insights of the Smoking Cessation & Nicotine De-Addiction Product Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Smoking Cessation & Nicotine De-Addiction Product Market

External macro-environmental factors deeply influence the performance of the Smoking Cessation & Nicotine De-Addiction Product Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Smoking Cessation & Nicotine De-Addiction Product Market

The Smoking Cessation & Nicotine De-Addiction Product Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Smoking Cessation & Nicotine De-Addiction Product Market

The Smoking Cessation & Nicotine De-Addiction Product Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Key Company Profiles

The report delves into recent significant developments in the Smoking Cessation & Nicotine De-Addiction Product Market, highlighting leading vendors and their innovative profiles. These include 22nd Century Group, Inc., Alkalon A/S, Axsome Therapeutics, Inc., British American Tobacco PLC, Cipla Ltd., Ditch Labs, Dr. Reddy’s Laboratories Limited, Enorama Pharma AB, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Imperial Tobacco Company of India Limited, Itaconix, Japan Tobacco Inc., Johnson & Johnson, JUUL Labs, Inc., Novartis International AG, Perrigo Company PLC, Pfizer Inc., Philip Morris International Inc., Pierre Fabre S.A., Rusan Pharma Ltd., Samyang Holdings Corporation, Sparsha Pharma International Pvt. Ltd., and Strides Pharma Science Limited.

Market Segmentation & Coverage

This research report categorizes the Smoking Cessation & Nicotine De-Addiction Product Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Drug Therapy
      • Chantix (Varenicline)
      • Zyban (Bupropion)
    • E-Cigarettes
    • Nicotine Inhalers
    • Nicotine Replacement Therapies
      • Nicotine Gums
      • Nicotine Lozenges
      • Nicotine Sprays
      • Nicotine Transdermal Patches
    • Nicotine Sublingual Tablets
  • Distribution
    • Drug Store
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Prevalence of Numerous Diseases due to Smoking Such as Respiratory Disorders and Lung Cancer
5.1.1.2. Expanding Market Penetration of De-Addiction Products Globally
5.1.1.3. Favorable Government Initiatives to Promote Anti-Smoking Policy and Raising Awareness of the Health Impact due to Smoking
5.1.2. Restraints
5.1.2.1. Product Recalls by the Manufacturer and Companies owing to increasing Technical Faults and Stringent Approval Process
5.1.3. Opportunities
5.1.3.1. Increasing Approvals and Development of New Nicotine Replacement Products
5.1.3.2. Significant Online Market Presence Coupled with Social and Communal Support for Smoking Cessation Products
5.1.4. Challenges
5.1.4.1. Side Effects Associated with the Continued Usage of De-Addiction Products Coupled with Rising of Alternatives to Tobacco
5.2. Market Segmentation Analysis
5.2.1. Product: Rising adoption of E-cigarettes for smoking cessation
5.2.2. Distribution: Customer inclination towards online pharmacies for convenience and discretion
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Smoking Cessation & Nicotine De-Addiction Product Market, by Product
6.1. Introduction
6.2. Drug Therapy
6.2.1. Chantix (Varenicline)
6.2.2. Zyban (Bupropion)
6.3. E-Cigarettes
6.4. Nicotine Inhalers
6.5. Nicotine Replacement Therapies
6.5.1. Nicotine Gums
6.5.2. Nicotine Lozenges
6.5.3. Nicotine Sprays
6.5.4. Nicotine Transdermal Patches
6.6. Nicotine Sublingual Tablets
7. Smoking Cessation & Nicotine De-Addiction Product Market, by Distribution
7.1. Introduction
7.2. Drug Store
7.3. Hospital Pharmacies
7.4. Online Pharmacies
7.5. Retail Pharmacies
8. Americas Smoking Cessation & Nicotine De-Addiction Product Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Smoking Cessation & Nicotine De-Addiction Product Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Smoking Cessation & Nicotine De-Addiction Product Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.3.1. BC Cancer Launches Nicotine Replacement Therapy Pilot Program in Prince George
11.3.2. Imperial Tobacco Canada Is Excited To Launch A Smoking Cessation Product
11.3.3. NCDHHS Launches New QuitlineNC Services to Make Stopping Tobacco Use and Vaping More Accessible
List of Figures
FIGURE 1. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET RESEARCH PROCESS
FIGURE 2. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET DYNAMICS
TABLE 7. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY CHANTIX (VARENICLINE), BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ZYBAN (BUPROPION), BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E-CIGARETTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE GUMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE LOZENGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE SPRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE SUBLINGUAL TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG STORE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 39. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 41. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 42. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 43. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 45. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 46. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 61. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 63. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 64. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 65. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 67. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 68. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 73. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 75. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 76. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 97. THAILAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. THAILAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 99. THAILAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 100. THAILAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. DENMARK SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. DENMARK SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 112. DENMARK SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 113. DENMARK SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 114. EGYPT SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. EGYPT SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 116. EGYPT SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 117. EGYPT SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 118. FINLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. FINLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 120. FINLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 121. FINLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 122. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 124. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 125. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 126. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 128. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 129. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 134. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 136. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 137. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 146. NORWAY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. NORWAY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 148. NORWAY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 149. NORWAY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 150. POLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. POLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 152. POLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 153. POLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 154. QATAR SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. QATAR SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 156. QATAR SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 157. QATAR SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 170. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 172. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 173. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 182. TURKEY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. TURKEY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 184. TURKEY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 185. TURKEY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 194. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 195. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Smoking Cessation & Nicotine De-Addiction Product Market, which are profiled in this report, include:
  • 22nd Century Group, Inc.
  • Alkalon A/S
  • Axsome Therapeutics, Inc.
  • British American Tobacco PLC
  • Cipla Ltd.
  • Ditch Labs
  • Dr. Reddy’s Laboratories Limited
  • Enorama Pharma AB
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Limited
  • Imperial Tobacco Company of India Limited
  • Itaconix
  • Japan Tobacco Inc.
  • Johnson & Johnson
  • JUUL Labs, Inc.
  • Novartis International AG
  • Perrigo Company PLC
  • Pfizer Inc.
  • Philip Morris International Inc.
  • Pierre Fabre S.A.
  • Rusan Pharma Ltd.
  • Samyang Holdings Corporation
  • Sparsha Pharma International Pvt. Ltd.
  • Strides Pharma Science Limited

Methodology

Loading
LOADING...

Table Information